Suchergebnisse - "Lim, Seng Gee"

PubPharm (394)

1

Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferon

enthalten in: Antiviral research | 2024

von Huang, D. | Shen, L. | Phyo, W. | +21

2

Efficacy, safety, and pharmacokinetics of capsid assembly modulator linvencorvir plus standard of care in chronic hepatitis B patients

enthalten in: Clinical and molecular hepatology | 2024

von Hou, J. | Gane, E. | Balabanska, R. | +23

CommentIn: Clin Mol Hepatol. 2024 Apr;30(2):164-165. - PMID 38447533

3

Single cell landscape of functionally cured chronic hepatitis B patients reveals activation of innate and altered CD4-CTL-driven adaptive immunity

enthalten in: Journal of hepatology | 2024

von Narmada, B. | Khakpoor, A. | Shirgaonkar, N. | +30

4

Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B : A Multicenter Longitudinal Study

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2024

von Chau, A. | Yeh, M. | Tsai, P. | +41

5

Additional Measures After Stopping Nucleoside Analogues in HbeAg-Negative Chronic Hepatitis B : Better But Not Enough

enthalten in: Gastroenterology | 2024

von Lim, S. | Tan, Y.

6

Ultrasensitive HBsAg testing predicts HBsAg seroreversion outcomes : Considerations for new and existing therapies

enthalten in: Journal of hepatology | 2023

von Anderson, M. | Holzmayer, V. | Stec, M. | +2

7

Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Huang, D. | Tran, A. | Yeh, M. | +35

CommentIn: Hepatology. 2023 Nov 1;78(5):1332-1333. - PMID 37246445

8

Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B

enthalten in: JHEP reports : innovation in hepatology | 2023

von Lim, Y. | Chan, H. | Ahn, S. | +21

9

WHO 2030 HBV elimination goals : a goal too far?

enthalten in: The lancet. Gastroenterology & hepatology | 2023

von Lim, S.

CommentOn: Lancet Gastroenterol Hepatol. 2023 Oct;8(10):879-907. - PMID 37517414

10

Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis : a REAL-C study

enthalten in: Hepatology international | 2023

von Wong, Y. | Tran, S. | Huang, C. | +81

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[40]